A groundbreaking study has uncovered a genetic predisposition driving alarmingly high rates of chronic kidney disease (CKD) among West Africans and people of African descent; The research, led by Professor Boima, highlights the prevalence of APOL1 gene variants as a significant risk factor and underscores the urgent need for public awareness, targeted screening, and improved access to treatment.
The findings revealed by released by Dr Dwomoa Adu, and a team of H3-Africa Kidney Disease Network researchers, have far-reaching implications, potentially revolutionizing kidney disease prevention and management strategies across affected populations.
The study's urgency is amplified by the stark reality of limited access to life-saving treatments in West Africa.
Affordable dialysis and kidney transplantation, considered the gold standard for end-stage renal disease, remain out of reach for many, exacerbating the burden of CKD in the region.
